YOLFTbeta
Instil Bio Inc.

Instil Bio Inc.

TIL · NASDAQ · Healthcare / Biotechnology

6.08USD-0.16 (-2.56%)

Price History

Full chart

Market Stats

Previous Close6.24
Open6.20
Day Range6.02 – 6.50
52-Week Range5.67 – 21.98
Volume51.63K
Market Cap48.63M
P/E (TTM)0.00
Forward P/E0.00
EPS-4.40
Dividend Yield0.00%
Beta1.92
50-Day Avg7.38
200-Day Avg8.15

About

Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Bronson Crouch
  • Employees17
  • Headquarters3963 Maple Avenue, Dallas, TX, United States, 75219, USA
  • Websitehttps://instilbio.com

Leadership

  • Mr. Bronson CrouchChairman & CEO · b. 1973
  • Dr. Sandeep Laumas M.D.CFO & Chief Business Officer · b. 1969

Financials

Income Statement

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue0138.00K00000
Growth (%)---100.00%----
Cost of Revenue20.00K-2.75M5.99M4.76M3.61M534.00K
Gross Profit-20.00K138.00K-2.75M-5.99M-4.76M-3.61M-534.00K
Gross Margin-100.00%-----
Operating Expense6.57M33.78M152.81M200.18M154.41M69.93M52.37M
Operating Income-6.58M-33.64M-155.56M-206.17M-159.17M-73.54M-52.91M
Operating Margin--24379.71%-----
EBITDA-6.50M-33.39M-152.81M-217.38M-147.12M-62.53M-65.01M
EBITDA Margin--24194.20%-----
Net Income-6.45M-37.74M-156.79M-223.18M-156.09M-74.14M-71.37M
Net Income Margin--27346.38%-----
R&D4.03M19.40M107.25M141.06M39.60M11.84M10.00M
R&D as % of Total Revenue-14057.25%-----
Interest Expense03.30M1.56M1.88M5.21M8.99M5.83M
Interest Expense % of Total Revenue-2391.30%-----

Balance Sheet

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets9.48M319.01M609.98M482.13M325.63M263.57M203.52M
Total Liabilities1.42M26.64M54.78M118.52M99.80M94.13M89.66M
Total Equity8.06M292.37M555.20M363.61M225.83M169.44M113.87M
Cash8.89M241.71M37.59M43.72M9.20M8.80M6.64M
Total Debt---79.90M86.05M86.89M85.18M
Net Debt-8.89M-241.71M-37.59M36.19M76.86M78.08M78.54M

Cash Flow

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-5.29M-29.62M-122.14M-180.16M-82.03M-55.70M-36.62M
Investing Cash Flow-760.00K-51.12M-474.40M114.54M41.13M53.97M25.48M
Financing Cash Flow14.95M313.05M393.16M71.89M8.08M1.75M7.29M
Capital Expenditure760.00K50.82M57.83M84.59M20.66M10.00M10.00M
Free Cash Flow-6.05M-80.43M-179.97M-264.75M-102.69M-65.70M-36.62M
FCF to OCF114.36%271.58%147.35%146.95%125.19%117.95%100.00%

Earnings

Report DateMar 22, 2021May 13, 2021Aug 12, 2021Nov 15, 2021Mar 7, 2022May 16, 2022Aug 12, 2022Nov 14, 2022Mar 31, 2023May 11, 2023Aug 14, 2023Nov 13, 2023Mar 21, 2024May 10, 2024Aug 13, 2024Nov 13, 2024Mar 19, 2025May 13, 2025Aug 13, 2025Nov 13, 2025Mar 27, 2026May 15, 2026Aug 13, 2026Nov 12, 2026
EPS Estimate0.00-11.90-4.00-6.13-0.36-6.50-8.27-8.20-0.41-3.20-2.00-3.00-3.40-2.23-3.04-3.08-3.65-2.59-2.44-2.35-3.78-0.59-0.35-
EPS Actual-0.15-13.20-5.40-6.60-0.43-8.40-9.20-8.60-0.24-5.00-2.20-3.20-1.26-3.74-1.57-2.55-1.08-4.32-2.88-2.01-0.97-0.62-0.63-
Surprise--10.92%-35.00%-7.67%-19.44%-29.23%-11.25%-4.88%41.46%-56.25%-10.00%-6.67%62.94%-67.71%48.36%17.21%70.41%-66.80%-18.03%14.47%74.34%-5.08%-80.00%-
TimingAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-After-hours-

Key Statistics & Ratios

Market Cap48.63M
Enterprise Value66.81M
Trailing P/E0.00
Forward P/E0.00
Price / Sales54248.82
Price / Book0.46
EPS-4.40
Book Value15.83
Revenue (TTM)0
Gross Profit (TTM)138.00K
EBITDA-36.66M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-25.33%
Return on Assets-10.77%
Shares Outstanding6.78M
Shares Float3.62M
Beta1.92
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 4 analystsTarget 7.00
  • Strong Buy
    2
  • Buy
    1
  • Hold
    1

Ownership Breakdown

Institutions
62.50%
Insiders
6.56%
Retail / Other
30.94%

Top Institutional Holders

  • BML Capital Management LLC
    645.60K9.52%
  • Cpmg Inc
    410.92K6.06%
  • Kalehua Capital Management LLC
    322.88K4.76%
  • Vivo Capital, LLC
    292.74K4.32%
  • Vanguard Capital Management, LLC
    174.58K2.57%
  • Millennium Management LLC
    134.57K1.98%
  • Renaissance Technologies Corp
    59.10K0.87%
  • BlackRock Inc
    52.02K0.77%
  • Delaware Management Holdings Inc
    50.00K0.74%
  • Geode Capital Management, LLC
    49.01K0.72%
  • LPL Financial Corp
    32.06K0.47%
  • Citadel Advisors Llc
    30.64K0.45%
  • XTX Topco Ltd
    26.24K0.39%
  • Vanguard Fiduciary Trust Co
    22.63K0.33%
  • Morgan Stanley - Brokerage Accounts
    19.82K0.29%
  • State Street Corp
    17.59K0.26%
  • Americana Partners, LLC
    16.18K0.24%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    118.99K1.75%
  • Nomura Healthcare Fund Class I
    50.00K0.74%
  • Fidelity Extended Market Index
    18.67K0.28%

Stock Splits

  • Dec 8, 20231:20